» Articles » PMID: 15541838

Preconditioning During Coronary Angioplasty: No Influence of Collateral Perfusion or the Size of the Area at Risk

Overview
Journal Eur Heart J
Date 2004 Nov 16
PMID 15541838
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: It is unclear whether the protection observed in human heart following repetition of brief episodes of ischaemia is due to opening of coronary collaterals or to ischaemic preconditioning. We investigated whether the improvement in ST segment change following repeated episodes of brief ischaemia during coronary angioplasty is due to preconditioning when the size of the area at risk and the collateral flow are taken into account.

Methods And Results: Thirty-six patients underwent percutaneous transluminal coronary angioplasty. Intracoronary ST segment changes were measured throughout the procedure and used as an endpoint. The size of the area at risk and the collateral perfusion within the ischaemic bed were measured using single photon emission computerized tomography (SPECT). Mean ST segment shift observed in all patients significantly decreased from 11.0+/-2.6 mm during the first balloon inflation to 8.5+/-2.3 mm during the second inflation. This protective effect occurred in the absence of any change in the size of the area at risk (mean: 46+/-5% of LV) and of the collateral perfusion to the ischaemic zone (mean: 23+/-4% of flow in the non-ischaemic zone).

Conclusion: These results suggest that ischaemic preconditioning does occur during repeated brief coronary artery occlusion in the human heart.

Citing Articles

Tensor cardiography: A novel ECG analysis of deviations in collective myocardial action potential transitions based on point processes and cumulative distribution functions.

Tsukada S, Iwasaki Y, Tsukada Y PLOS Digit Health. 2024; 3(8):e0000273.

PMID: 39116062 PMC: 11309480. DOI: 10.1371/journal.pdig.0000273.


Ischemic Preconditioning and Coronary Collateral Blood Flow Increment: Two Sides of the Same Coin?.

Santillo E, Fallavollita L, Marini L Acta Cardiol Sin. 2019; 35(6):659.

PMID: 31879521 PMC: 6859105. DOI: 10.6515/ACS.201911_35(6).20181101B.


Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?.

Kleinbongard P, Botker H, Ovize M, Hausenloy D, Heusch G Br J Pharmacol. 2019; 177(23):5252-5269.

PMID: 31430831 PMC: 7680006. DOI: 10.1111/bph.14839.


Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Botker H, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson S Basic Res Cardiol. 2018; 113(5):39.

PMID: 30120595 PMC: 6105267. DOI: 10.1007/s00395-018-0696-8.


Influence of preinfarction angina and coronary collateral blood flow on the efficacy of remote ischaemic conditioning in patients with ST segment elevation myocardial infarction: post hoc subgroup analysis of a randomised controlled trial.

Pryds K, Bottcher M, Sloth A, Munk K, Schmidt M, Botker H BMJ Open. 2016; 6(11):e013314.

PMID: 27884851 PMC: 5168541. DOI: 10.1136/bmjopen-2016-013314.